SCHEMBL21941682

SCHEMBL21941682

NC(=O)Cc1cnc2cc(C3CCC3)ccn12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 1/20 0.34
PLAU P00749 2/20 0.33
FASN P49327 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ABL1 P00519 2/20 0.32
GGPS1 O95749 1/20 0.32
FDPS P14324 1/20 0.32
AKT1 P31749 1/20 0.31
AKT2 P31751 1/20 0.31
KIT P10721 1/20 0.31
ACMSD Q8TDX5 1/20 0.31
LNPEP Q9UIQ6 1/20 0.31
KMO O15229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21577725 0.97 KDM4E (0.35) USP7PLAUKDM4EGLAHTT
SCHEMBL23651853 0.96 SMN1; SMN2 (0.37) USP7PLAUKDM4EGLAHTT
SCHEMBL5767283 0.76 KDR (0.48) KDM4EGLAGGPS1FDPSKDR
SCHEMBL2260984 0.76 KDM4E (0.52) KDM4EGLASMN1; SMN2TDP1L3MBTL1
SCHEMBL23103322 0.74 GRM2 (0.42) USP7FASNKDM4EGLAAKT1
SCHEMBL2267420 0.73 PRMT5 (0.43) GGPS1FDPSKITKDR
SCHEMBL14750974 0.73 KDM4E (0.47) KDM4EGLAHTTKMT2ASMN1; SMN2
SCHEMBL2265948 0.73 PRMT5 (0.42) KDM4ESMN1; SMN2KITALDH1A1PKM
SCHEMBL633944 0.71 GGPS1 (0.57) PLAUKDM4EGLASMN1; SMN2GGPS1
SCHEMBL2262242 0.68 ADORA3 (0.37) ABL1GGPS1FDPSKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300948-A1 1H-PYRROLE-2,5-DIONE COMPOUNDS AND METHODS OF USING THEM TO INDUCE SELF-RENEWAL OF STEM/PROGENITOR SUPPORTING CELLS Frequency Therapeutics, Inc. 2021-09-30 US disclosed
US-20200113913-A1 METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION Frequency Therapeutics, Inc. 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200113913-A1 METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION SHH, WNT3A, WNT1 USP7 416/4885PLAU 3288/4885FASN 847/4885
US-20210300948-A1 1H-PYRROLE-2,5-DIONE COMPOUNDS AND METHODS OF USING THEM TO INDUCE SELF-RENEWAL OF STEM/PROGENITOR SUPPORTING CELLS MCL1, PROX1, MKI67 USP7 3377/4885PLAU 3479/4885FASN 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.